KMDA Q1 2022 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+12.8% YoY

Gross Profit

$11M40.2% margin

Operating Income

$246,0000.9% margin

Net Income

-$2M-6.5% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-10.7%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$5M

Stock-Based Comp.

$193,000

Balance Sheet

Total Assets

$303M

Total Liabilities

$128M

Stockholders' Equity

$175M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$25M	+12.8%
Gross Profit	$11M	$9M	+26.5%
Operating Income	$246,000	$2M	-89.6%
Net Income	-$2M	$3M	-168.0%